课题基金 / 基金详情

EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations

EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
EyeStar-BIO:用于增强数字双目间接检眼镜检查的软件
批准号:
10824075
负责人:
Jeffrey Wigdahl
金额:
$5.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2023-11-30

项目摘要

项目成果

Jeffrey Wigdahl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary The goal of the proposed project is to develop EyeStar-BIO, a suite of software tools designed to enhance digital binocular indirect ophthalmoscopy examinations (BIO), one of the most common forms of examination of the retina. Using BIO, an ophthalmologist can determine the presence of multiple retinal diseases such as diabetic retinopathy, macular degeneration, and retinopathy of prematurity, among others. The traditional BIO exam does not produce any visual documentation. EyeStar-BIO will provide tools to enhance digital BIO exams such as: 1) selecting best quality images, 2) generating a wide field view of the retina, 3) monitoring changes over time, and 4) diagnosing retinal diseases using artificial intelligence. The goals of this Phase I project will be accomplished via three specific aims: • Aim 1: implement software for automatic image quality assessment of digital BIO video frames. • Aim 2: develop image stitching methods to generate a wide field view of the retina using the best quality frames in the video. • Aim 3: generate images to track differences in time due to disease progression or regression. The EyeStar-BIO software will be licensed to manufacturers of digital BIO headsets. Future developments will include real time implementations of EyeStar-BIO and the ability to diagnose retinal disease using artificial intelligence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
  • 批准号:
    10383202
  • 项目类别:
  • 资助金额:
    $24.76万
  • 财政年份:
    2022
  • 负责人:
    Jeffrey Wigdahl
  • 依托单位:
海外基金